BioSpace News Archive

Ovid Therapeutics Inc., a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, will present data on safety, tolerability, exploratory and secondary outcomes from the Phase 1b/2a clinical trial of OV935/TAK-935 in adult patients with developmental and epileptic encephalopathies.

Healthcare startup Ezra expands its offering to full-body MRI-based cancer screening

Sonendo®, announced it will participate in the Stifel 2019 Dental & Veterinary Conference on Wednesday, May 29th, 2019, in New York, N.Y.

Bausch Health Companies Inc. announced the results to date of its pending cash tender offers to purchase up to $1,500,000,000 aggregate principal amount of its outstanding notes listed in the table below, as well as the anticipated early settlement date for the Tender Offers on May 24, 2019.

he leveraged finance and private equity community came together yesterday to raise a record-breaking $2.4 million dollars in the fight again melanoma.

Opsani, the leading provider of AI-driven continuous optimization for cloud applications, has entered into an agreement with Ancestry®, the global leader in family history and consumer genetics services

Largest dental support organization once again holds its premier aesthetic education program

Redbud Labs (“Redbud”) announced today an expansion to its MXRTM (“mixer”) microfluidic chip family with the introduction of MXRTM BLUE. T

A trend is developing: gamers and live content creators are using their platforms to make a positive impact on other people.